LAY, LUIGI
 Distribuzione geografica
Continente #
EU - Europa 7.356
NA - Nord America 5.818
AS - Asia 4.789
SA - Sud America 531
AF - Africa 156
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 7
Totale 18.679
Nazione #
US - Stati Uniti d'America 5.683
GB - Regno Unito 1.987
IT - Italia 1.783
CN - Cina 1.648
SG - Singapore 1.140
DE - Germania 783
SE - Svezia 774
RU - Federazione Russa 500
HK - Hong Kong 449
IN - India 432
BR - Brasile 395
TR - Turchia 350
NL - Olanda 338
FR - Francia 284
IE - Irlanda 228
KR - Corea 220
UA - Ucraina 200
FI - Finlandia 155
VN - Vietnam 112
JP - Giappone 105
EU - Europa 91
ID - Indonesia 86
CI - Costa d'Avorio 77
CA - Canada 61
DK - Danimarca 59
BE - Belgio 48
MX - Messico 46
CO - Colombia 45
BD - Bangladesh 41
PL - Polonia 41
PH - Filippine 37
AR - Argentina 36
ES - Italia 35
CH - Svizzera 27
PK - Pakistan 27
AT - Austria 23
TW - Taiwan 23
GR - Grecia 20
ZA - Sudafrica 20
MA - Marocco 19
SA - Arabia Saudita 19
AU - Australia 18
IQ - Iraq 16
EC - Ecuador 14
NO - Norvegia 11
PT - Portogallo 11
CL - Cile 10
PE - Perù 10
UZ - Uzbekistan 10
CZ - Repubblica Ceca 9
EG - Egitto 9
KE - Kenya 9
RO - Romania 9
VE - Venezuela 9
MD - Moldavia 8
TH - Thailandia 8
CU - Cuba 7
IL - Israele 7
IR - Iran 7
AE - Emirati Arabi Uniti 6
DZ - Algeria 5
KZ - Kazakistan 5
NP - Nepal 5
SK - Slovacchia (Repubblica Slovacca) 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BG - Bulgaria 4
JO - Giordania 4
AL - Albania 3
AM - Armenia 3
AZ - Azerbaigian 3
BO - Bolivia 3
BS - Bahamas 3
KG - Kirghizistan 3
MO - Macao, regione amministrativa speciale della Cina 3
MY - Malesia 3
NZ - Nuova Zelanda 3
OM - Oman 3
PY - Paraguay 3
SV - El Salvador 3
UY - Uruguay 3
BB - Barbados 2
BY - Bielorussia 2
ET - Etiopia 2
GY - Guiana 2
HN - Honduras 2
HR - Croazia 2
JM - Giamaica 2
LB - Libano 2
LV - Lettonia 2
MW - Malawi 2
NG - Nigeria 2
PS - Palestinian Territory 2
TJ - Tagikistan 2
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
BM - Bermuda 1
Totale 18.739
Città #
Southend 1.808
Milan 928
Singapore 619
Chandler 482
Ashburn 466
Dallas 431
Hong Kong 423
Seattle 379
Beijing 353
Hanover 282
Princeton 270
Dublin 222
Wilmington 222
Council Bluffs 209
Fairfield 207
Mountain View 195
Dearborn 190
Ann Arbor 181
Redmond 143
Los Angeles 134
Woodbridge 114
Santa Clara 113
Hefei 108
Jacksonville 105
Nanjing 100
Bengaluru 94
Des Moines 94
Guangzhou 82
Houston 81
Sakarya 81
Frankfurt am Main 79
Buffalo 78
Abidjan 77
Cambridge 71
Moscow 70
Boardman 63
New York 57
Munich 53
Redwood City 53
Columbus 51
Jakarta 50
Jinan 49
Serra 48
Shanghai 47
Somerville 44
Tokyo 42
Shenyang 41
The Dalles 41
Berlin 40
Bogotá 39
Phoenix 39
Seoul 39
Cangzhou 38
Andover 37
Brussels 36
Istanbul 33
Rome 33
Changsha 32
San Diego 32
Eitensheim 31
Medford 31
Hangzhou 30
São Paulo 30
Nanchang 27
Ho Chi Minh City 26
Lappeenranta 26
Pisa 26
Hebei 25
Tianjin 24
Warsaw 24
Bühl 23
Paris 21
Pune 21
Kent 20
Chicago 19
Florence 19
Hanoi 19
Dong Ket 18
Fuzhou 18
Helsinki 18
Jiaxing 18
London 18
Rio de Janeiro 18
Shenzhen 18
Athens 17
Silver Spring 17
San Francisco 16
Wuhan 16
Zhengzhou 15
Haikou 14
Kunming 14
Ponte San Pietro 14
Toronto 14
Xiamen 14
Lanzhou 13
Odernheim 13
Quanzhou 13
Dhaka 12
Montreal 12
Mumbai 12
Totale 11.322
Nome #
A NEW PROCEDURE FOR THE SYNTHESIS OF AZASUGARS 603
A stabilized glycomimetic conjugate vaccine inducing protective antibodies against Neisseria meningitidis serogroup A 423
Combined chemical synthesis and tailored enzymatic elongation provide fully synthetic and conjugation-ready Neisseria meningitidis serogroup X vaccine antigens 302
Preparation and immunogenicity of gold glyco-nanoparticles as antipneumococcal vaccine model 285
Synthesis and biological evaluation of a trisaccharide repeating unit derivative of Streptococcus pneumoniae 19A capsular polysaccharide 279
Vaccini antibatterici glicoconiugati: sintesi di fosfono analoghi di frammenti del polisaccaride capsulare del N. meningitidis tipo A 270
Factors affecting T cell responses induced by fully synthetic glyco-gold-nanoparticles 270
GLUCOSE-DERIVED IONIC LIQUIDS: EXPLORING LOW-COST SOURCES FOR NOVEL CHIRAL SOLVENTS 249
Exploring glycosylation reactions under continuous-flow conditions 242
Emerging glyco-based strategies to steer immune responses 242
Carbohydrate-derived ionic liquids : Exploring the chiral pool for novel reaction media 233
Recent advances on smart glycoconjugate vaccines in infections and cancer 232
Vaccini antibatterici glicoconiugati : sintesi di analoghi stabilizzati di frammenti del polisaccaride capsulare del N. meningitidis tipo A 210
Design, preparation and biological evaluation of a small library of compounds containing the common disaccharide of Streptococcus pneumoniae 19F and 19A capsular polysaccharides 204
HRMAS NMR analysis in neat ionic liquids : a powerful tool to investigate complex organic molecules and monitor chemical reactions 200
Glycosylation with trichloroacetimidates in ionic liquids: influence of the reaction medium on the stereochemical outcome 198
Glucose-derived ionic liquids: exploring low-cost sources for novel chiral solvents 197
Influence of surface coating on the intracellular behaviour of gold nanoparticles : a fluorescence correlation spectroscopy study 196
The Conformation of the Mannopyranosyl Phosphate Repeating Unit of the Capsular Polysaccharide of Neisseria meningitidis Serogroup A and Its Carba-Mimetic 195
Novel carbohydrate-based bifunctional organocatalysts for nucleophilic addition to nitroolefins and imines 193
Probing specific protein recognition by size-controlled glycosylated cyclodextrin nanoassemblies 191
NMR evidence for the participation of triflated ionic liquids in glycosylation reaction mechanisms 190
Gold nanoparticles as carriers of streptococcus pneumoniae carbohydrate antigens fully synthetic vaccines 189
(alpha-L-rhamnopyranosyl)methylphosphonic acids : experimental evidence of the analogy with alpha-L-rhamnopyranosyl phosphate 188
Synthesis and biological evaluation of phosphono analogues of Neisseria meningitidis A capsular polysaccharide fragments. 187
Exploiting the cross-metathesis reaction in the synthesis of pseudo-oligosaccharides 182
Carbohydrates and Immunology : Synthetic Oligosaccharide Antigens for Vaccine Formulation 182
Recent Advances in the Synthesis of Glycoconjugates for Vaccine Development 182
Design, preparazione e valutazione biologica di una piccola collezione di composti contenenti il disaccaride comune alle capsule polisaccaridiche di Streptococcus pneumoniae 19F e 19A 182
Glycosylation with trichloroacetimidates in ionic liquids: a "green" approach to the synthesis of glycosides 179
Gold nanoparticle-based platforms for vaccine development 177
Synthesis of stabilized analogues of fragments of Neisseria meningitidis type A capsular polysaccharide 176
Synthesis of the phosphono analogue of the dimeric subunit of Neisseria meningitidis type A capsular polysaccharide 174
Simple synthesis of versatile coumarin scaffolds 174
Efficient Synthesis of O-, S-, N- and C-Glycosides of 2-Amino-2-Deoxy-D-Glucopyranose from Glycosyl Iodides 173
Synthesis of phosphono analogues of fragments of Neisseria meningitidis type A capsular polysaccharide 171
Glycoporphyrin catalysts for efficient C-H bond aminations by organic azides 170
Synthesis of phosphorylated fragments of Streptococcus pneumoniae type 19F capsular polysaccharide 169
Synthesis, molecular dynamics simulations, and biology of a carba-analogue of the trisaccharide repeating unit of Streptococcus pneumoniae 19F capsular polysaccharide 163
Glycan Array Evaluation of Synthetic Epitopes between the Capsular Polysaccharides from Streptococcus pneumoniae 19F and 19A 163
Synthesis of neisseria meningitidis x capsular polysaccharide fragments 158
Impact of ConcanavalinA affinity in the intracellular fate of Protein Corona on Glucosamine Au nanoparticles 158
Identification of O-sulphate substituents on D-glucuronic acid units in heparin-related glycosaminoglycans using novel synthetic disaccharide standards 157
Modeling of synthetic phosphono and carba analogues of N-acetyl-alpha-D-mannosamine 1-phosphate, the repeating unit of the capsular polysaccharide from Neisseria meningitidis serovar A 154
Multivalent, Saccharide-Functionalized Gold Nanoparticles as Fully Synthetic Analogs of Type A Neisseria meningitidis Antigens 153
Fluidic Manufacture of Star-Shaped Gold Nanoparticles 153
Synthesis of Fragment of beta-Glucans as Potential Ligands for Dectin-1 152
Gold nanoparticles morphology does not affect the multivalent presentation and antibody recognition of Group A Streptococcus synthetic oligorhamnans 152
Synthesis and immunological evaluation of protein conjugates of neisseria meningitidis X capsular polysaccharide fragments 151
Synthesis of a Structural Analogue of the Repeating Unit from Streptococcus pneumoniae 19F Capsular Polysaccharide Based on the Cross-Metathesis−Selenocyclization Reaction Sequence 150
Major advances in the development of synthetic oligosaccharide-based vaccines 150
Cyclodextrin nanoaggregates and their assembly with protein: a spectroscopic investigation 147
Synthesis and Preliminary Biological Evaluation of Carba Analogues from Neisseria meningitidis A Capsular Polysaccharide 145
Expeditious synthesis of water-soluble, monolayer-protected gold nanoparticles of controlled size and monolayer composition 144
Efficient Synthesis of Unsymmetrical Ureido-Linked Disaccharides 144
Immunoactivity of Protein Conjugates of Carba Analogues from Neisseria meningitidis A Capsular Polysaccharide 143
A small library of compounds, containing the common disaccharide of Streptococcus pneumoniae 19F and 19A capsular polysaccharides, as novel non-natural antibacterial saccharide antigens 143
Combining cross-coupling reaction and Knoevenagel condensation in the synthesis of glyco-BODIPY probes for DC-SIGN super-resolution bioimaging 143
Easy chemo-enzymatic synthesis of human milk trisaccharides from a common selectively protected lactose building block 141
Solution Synthesis of Two Orthogonally Protected Lactosides as Tetravalent Disaccharide-Based Scaffolds 140
Photo-Induced Microfluidic Production of Ultrasmall Glyco Gold Nanoparticles 139
SYNTHETIC STUDIES ON ALPHA-C-GLYCOSIDES OF D-GLUCOSAMINE 138
Stable Antibacterial glycoconjugate vaccines: Synthesis of phosphono analogues of fragments of Neisseria meningitidis type A capsular polysaccharide 135
Synthesis of C-disaccharides through dimerization of exo-glycals 134
Synthesis of Lewis A and Lewis X pentasaccharides based on N-trichloroethoxycarbonyl protection 133
A convenient multigram preparation of functionalized 2-azido-2-deoxy-D-mannose as a useful orthogonally protected building block for oligosaccharide synthesis 133
GLYCOSYL SULFATES AS GLYCOSYL DONORS 132
Semisynthetic Glycoconjugates as Potential Vaccine Candidates Against Haemophilus influenzae Type a 130
Compounds 130
Synthesis of carba-analogues of n-acetyl-d-mannosamine suitable for conjugation to superparamagnetic iron oxide nanoparticles (spion) 129
A simple access to lactose-derived building blocks required in glycoconjugate synthesis 124
Amphiphilic N-glycosyl-thiocarbamoyl cyclodextrins: synthesis, selfassembly and fluorimetry of recognition by Lens culinaris lectin. 123
Synthesis of antimetabolites of sucrose 123
Trichloroacetimidates as glycosyl donors in recyclable ionic liquids 123
Exploring new methods to control the stereoselectivity of glycosylation reactions 122
Antibacterial Carbohydrate Vaccines 121
Chemical contributions to understanding heparin activity: Synthesis of related sulfated oligosaccharides 121
Oligosaccharides Related to Tumor-Associated Antigens. Part I. Synthesis of the propyl glycoside of the trisaccharide α-L-Fucp-(1 → 2)-β-D-Galp-(1 → 3)-β-D-GalpNAc, component of a tumor antigen recognized by the antibody MBr1 121
A strategy for multivalent presentation of carba analogues from N. meningitidis A capsular polysaccharide 121
Iron and Ruthenium Glycoporphyrins: Active Catalysts for the Synthesis of Cyclopropanes and Aziridines 120
Phosphorylation of the Synthetic Hexasaccharide Repeating Unit Is Essential for the Induction of Antibodies to Clostridium difficile PSII Cell Wall Polysaccharide 120
Boranophosphate diesters as stable synthetic analogues of 1-O-glycosylphosphates 118
Synthetic approach to Kdo glycosides via exo-glycal epoxides and rationalization of the stereo chemical outcome 116
SYNTHETIC GLYCOSAMINOGLYCAN PENTASACCHARIDES FOR INHIBITION OF ENZIMATIC ACTIVITY OF HEPARANASE 115
Synthesis of Neisseria meningitidis X capsular polysaccharide fragments 115
Elucidating the role of N-acetylglucosamine in Group A Carbohydrate for the development of an effective glycoconjugate vaccine against Group A Streptococcus 113
Stereoselective synthesis of the isosteric phosphono analogues of N-acetyl-alpha-D-glucosamine 1-phosphate and N-acetyl-alpha-D-mannosamine 1-phosphate 113
Regioselective acylation of disaccharides by enzymatic transesterification 113
Synthesis of di- and tri-saccharide fragments of Salmonella typhi Vi capsular polysaccharide and their zwitterionic analogues 113
Synthesis of fragments of Salmonella Typhi capsular polysaccharide and their zwitterionic analogues 112
Lipase-catalysed regioselective acylations in combination with regioselective glycosylations as a strategy for the synthesis of oligosaccharides: Synthesis of a series of fucosyllactose building blocks 111
Improvement on lipase catalysed regioselective O-acylation of lactose: A convenient route to 2 '-O-fucosyllactose 111
Synthesis of fragments of salmonella Typhi capsular polysaccharide and their zwitterionic analogues 111
A rational approach to heparin-related fragments - Synthesis of differently sulfated tetrasaccharides as potential ligands for fibroblast growth factors 108
Minimal heparin/heparan sulfate sequences for binding to fibroblast growth factor-1 108
Oligosaccharides related to tumor-associate antigens. Part 3. Synthesis of the propyl glycosides of the trisaccharide β-D-Galp-(1→3)-β-D-GalpNAc-(1→3)-α-D-Galp and of the Tetrasaccharide α-L-Fucp-(1→2)-β-D-Galp-(1→3)-β-D-GalpNAc-(1→3)-α-D-Galp, components of a tumor antigen recognized by the antibody MBr1 107
Synthesis of fragments of Salmonella thyphi capsular polysaccharide and their zwitterionic analogues 106
A Synthetic Disaccharide Analogue from Neisseria meningitidis A Capsular Polysaccharide Stimulates Immune Cell Responses and Induces Immunoglobulin G (IgG) Production in Mice When Protein-Conjugated 106
Synthesis of disaccharidic sub-units of a new series of heparin related oligosaccharides 105
Improvement of the synthesis of immunological carbohydrate vaccines containing the tumour associate antigen CaMBr1 105
Totale 16.541
Categoria #
all - tutte 53.309
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.309


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.170 0 0 0 0 137 93 71 78 171 149 364 107
2021/20221.839 147 71 62 115 175 140 184 142 123 192 189 299
2022/20231.923 240 224 176 187 204 368 65 104 194 28 73 60
2023/20241.243 45 98 53 78 248 77 43 74 29 110 204 184
2024/20253.531 188 287 73 296 268 186 146 377 169 375 338 828
2025/20262.774 598 586 714 627 249 0 0 0 0 0 0 0
Totale 19.646